Quarterly ResultMay 7, 2026, 04:20 PM
SkinHealth Systems Q1 Net Sales $64.9M, Adj. EBITDA $8.5M; Lowers FY26 Outlook
AI Summary
SkinHealth Systems reported first-quarter 2026 financial results, with net sales of $64.9 million, a 6.7% decrease year-over-year, and a net loss of $6.6 million. Despite the revenue decline, the company significantly outperformed on adjusted EBITDA, which rose to $8.5 million from $7.3 million in Q1 2025, driven by lower operational spend. The company is lowering its full-year 2026 net sales outlook to $280-$295 million, citing continued pressure on device sales and a challenging market, while maintaining its adjusted EBITDA guidance.
Key Highlights
- Q1 2026 Net sales decreased 6.7% to $64.9 million from $69.6 million in Q1 2025.
- Q1 2026 Net loss improved to $(6.6) million from $(10.1) million in Q1 2025.
- Q1 2026 Adjusted EBITDA increased to $8.5 million (13.1% margin) from $7.3 million (10.4% margin) in Q1 2025.
- Q1 2026 Gross margin was 68.5%, down from 69.8% in Q1 2025; Adjusted gross margin was 72.2%.
- Total delivery systems sold in Q1 2026 were 746, down from 862 in Q1 2025.
- Revised FY 2026 net sales guidance is $280-$295 million, lowered from previous outlook.
- Americas net sales were $44.6 million, APAC $6.6 million, and EMEA $13.7 million in Q1 2026.
Price Impact
More from SKIN